Quarterly Activity Chart
Adds vs. Reduces by Quarter
PaperPanda Equity Terminal
LYEL —
LYELL IMMUNOPHARMA INC
CUSIP: 55083R203 · Held by 2 superinvestors · Combined value: $11,702,279
Latest News
Loading financials…
| # | Investor | % of Portfolio | Value ($) | Shares | Recent Activity | Share Change |
|---|---|---|---|---|---|---|
| 1 | Ken Griffin | 0.0% | $10,486,777 | 340,701 | REDUCE | -15,540 |
| 2 | Jim Simons | 0.0% | $1,215,502 | 39,490 | REDUCE | -24,500 |
| Investor | Activity | Share Change | % Change |
|---|---|---|---|
| Jim Simons | REDUCE | -24,500 | -38.3% |
| Ken Griffin | REDUCE | -15,540 | -4.4% |
| Investor | Activity | Share Change | % Change |
|---|---|---|---|
| Ken Griffin | ADD | +68,968 | +24.0% |
| Jim Simons | REDUCE | -3,200 | -4.8% |
Who Owns LYEL? Superinvestor Holdings
LYELL IMMUNOPHARMA INC is held by 2 tracked superinvestors, with a combined position value of $12 million . The largest positions are held by Ken Griffin (0.0% of portfolio), Jim Simons (0.0% of portfolio).
In the most recent quarter2 reduced or exited.